Active colloids are a class of microparticles that ‘swim’ through fluids by breaking the symmetry of the force distribution on their surfaces. Our ability to direct these particles along complex trajectories in three-dimensional (3D) space requires strategies to encode the desired forces and torques at the single particle level. Here, we show that spherical colloids with metal patches of low symmetry self-propel along non-linear 3D trajectories when powered remotely by an alternating current (AC) electric field. In particular, particles with triangular patches of approximate mirror symmetry trace helical paths along the axis of the field. We demonstrate that the speed and shape of the particle’s trajectory can be tuned by the applied field strength and the patch geometry. We show that helical motion can enhance particle transport through porous materials with implications for the design of microrobots that can navigate complex environments.

As part of an ongoing search for immunomodulatory components aimed at the anti-complementary effect, ginsenosides isolated from processed ginseng were found to have inhibitory activity on complement activation through classical pathways. Activity-guided fractionation was used to isolate four ginsenosides, namely ginsenoside Rg 6 , F 4 , Rk 3, and Rh 4 . Ginsenoside Rk 3 and Rh 4 had a 3 fold higher inhibition activity than rosmarinic acid which was used as a positive control while ginsenoside Rg 6 and F 4 showed only mild effects similar to that of the positive control. The results suggest that the activity of the corresponding ginsenosides may be increased by the glycosyl moiety at the C 6 position rather than the double bond conformation at C 20 , and ginsenoside Rk 3 and Rh 4 could have a role in treating inflammatory diseases.

Comprehensive metabolomics analysis is an effective method of measuring metabolite levels in the body following administration of a pharmaceutical compound and can allow for monitoring of the effects of the compound or assessment of appropriate treatment options for individual patients. In the present metabolomics study, samples pretreated with antiplatelet compounds were extracted and subjected to ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry. The acquired data were processed using peak clustering and evaluated by partial least-squares (PLS) and orthogonal projections to latent structures discriminant analyses (OPLS-DA). As a result, meaningful endogenous metabolites, namely eicosanoids and thromboxane B(2) (TXB(2)), were identified. TXB(2), a key element in platelet aggregation, was decreased upon ginsenoside Rk(1) treatment via inhibition of cyclooxygenase (COX) activity. One of the arachidonic acid (AA) metabolites, 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE), was decreased significantly in the ginsenoside Rk(1)-treated platelets compared to the AA-induced group. In the mechanism study of ginsenoside Rk(1), a strong linkage to intracellular calcium levels, which induce platelet activation, was found. Additionally, the translocation of 12-LOX from cytosol to membrane, which is related with the intracellular calcium levels, was determined. Therefore, a decreased 12-HETE level induced by ginsenoside Rk(1) on antiplatelet aggregation is related to 12-LOX translocation resulting from decreased Ca(2+) levels. This study shows that global metabolomic analysis has potential for use in understanding the biological behavior of antiplatelet drugs.

No abstract

No abstract